COMP <GO>
PGNY vs LLY // EV/EBITDA & P/E VALUATION
Progyny Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: PGNY 2
— LLY 11
▲ EV/EBITDA & P/E VALUATION LEADER: PGNY
LAST: $28.40 (+1.90%) • MKT CAP: $2.18B
valuation
20.5x
LAST: $1,373.70 (+6.63%) • MKT CAP: $1.29T
valuation
36.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PGNY VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PGNY | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.60% | 83.64% | -60.04 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.70% | 32.36% | -15.66 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 20.5x | 36.4x | -15.92 | PGNY | /valuation <GO> |
| Free Cash Flow Yield | 8.80% | 2.30% | +6.50 | PGNY | /fcf-yield <GO> |
| Operating Margin | 6.60% | 40.21% | -33.61 | LLY | /operating-margins <GO> |
| Net Profit Margin | 4.50% | 31.90% | -27.40 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 10.40% | 45.51% | -35.11 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.84 | 9.29 | -0.45 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.77% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.0 | 66.6 | -4.58 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.51 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.6x | 26.3x | +8.35 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.18B | $1.29T | -$1.29T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PGNY REV | LLY REV | PGNY GROSS % | LLY GROSS % | PGNY FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.29B | $65.18B | 23.6% | 83.0% | $191.8M | $16.81B |
| FY 2024 | $1.17B | $45.04B | 21.7% | 81.3% | $173.7M | $8.82B |
| FY 2023 | $1.09B | $34.12B | — | 79.3% | $188.8M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PGNY // BETA —
LLY // BETA 0.51